Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 07 2018
accepted: 24 08 2018
pubmed: 6 9 2018
medline: 5 3 2020
entrez: 6 9 2018
Statut: ppublish

Résumé

Social cognition deficits have been observed in individuals at clinical high risk (CHR) for psychosis. Longitudinal change in social cognition were analyzed in CHR individuals from the North American Prodrome Longitudinal Study (NAPLS2) based on outcome at 24 months. Individuals (n = 359) were classified into remission, symptomatic, prodromal progression and transition to psychosis (CHR-T) groups. Social cognition was assessed using theory of mind, emotion perception, and social perception tasks. There were no differences at baseline or 24 months between the groups on social cognition. Non-transition groups improved significantly over time on social cognition, but CHR-T did not show this effect.

Identifiants

pubmed: 30181061
pii: S0920-9964(18)30545-0
doi: 10.1016/j.schres.2018.08.032
pmc: PMC6395507
mid: NIHMS1505627
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

334-336

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH082022
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081984
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081902
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH080272
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081988
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH066286
Pays : United States
Organisme : NIMH NIH HHS
ID : K24 MH076191
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH060720
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081928
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081857
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH082004
Pays : United States

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Références

Schizophr Res. 2011 Sep;131(1-3):11-7
pubmed: 21757324
J Neurosci Methods. 2002 Apr 15;115(2):137-43
pubmed: 11992665
Schizophr Res. 2012 Jan;134(1):1-9
pubmed: 22056201
Eur Child Adolesc Psychiatry. 2018 Jun;27(6):683-700
pubmed: 28914382
Schizophr Bull. 2012 Jun;38(4):854-64
pubmed: 21345917
Neuroimage. 2011 Mar 1;55(1):329-37
pubmed: 21147235
Neuropsychopharmacology. 2010 Apr;35(5):1053-62
pubmed: 20090669
Br J Psychiatry Suppl. 2007 Dec;51:s52-7
pubmed: 18055938
Psychiatry Res. 2009 Mar 31;166(1):54-62
pubmed: 19193447
Schizophr Res. 2016 Mar;171(1-3):176-81
pubmed: 26785807
Schizophr Res. 2011 Aug;130(1-3):170-5
pubmed: 21620681
Schizophr Res. 2012 Dec;142(1-3):77-82
pubmed: 23043872
J Head Trauma Rehabil. 2003 May-Jun;18(3):219-38
pubmed: 12802165
Front Psychiatry. 2018 Apr 24;9:157
pubmed: 29740360
Schizophr Res Cogn. 2015 Sep;2(3):133-139
pubmed: 27695675
Psychiatry Res. 2014 May 15;216(2):206-12
pubmed: 24582775
J Nerv Ment Dis. 2015 May;203(5):328-35
pubmed: 25919383
JAMA Psychiatry. 2016 Dec 1;73(12):1239-1248
pubmed: 27806157
Arch Gen Psychiatry. 2010 Jun;67(6):578-88
pubmed: 20530007
Disabil Rehabil. 2006 Dec 30;28(24):1529-42
pubmed: 17178616
Schizophr Bull. 2014 Jul;40(4):813-23
pubmed: 23728248

Auteurs

M K Shakeel (MK)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.

L Lu (L)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.

T D Cannon (TD)

Department of Psychology, Yale University, New Haven, CT, United States.

K S Cadenhead (KS)

Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.

B A Cornblatt (BA)

Department of Psychiatry, Zucker Hillside Hospital, Queens, NY, United States.

T H McGlashan (TH)

Department of Psychiatry, Yale University, New Haven, CT, United States.

D O Perkins (DO)

Department of Psychiatry, University of North Carolina, Chapel Hill, NC, United States.

L J Seidman (LJ)

Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts General Hospital, Boston, MA, United States.

M T Tsuang (MT)

Department of Psychiatry, University of California San Diego, La Jolla, CA, United States; Institute of Genomic Medicine, University of California, La Jolla, CA, United States.

S W Woods (SW)

Department of Psychiatry, Yale University, New Haven, CT, United States.

E F Walker (EF)

Department of Psychology, Emory University, Atlanta, GA, United States.

D H Mathalon (DH)

Department of Psychiatry, University of California, San Francisco, San Francisco, United States; Psychiatry Service, San Francisco, CA, United States.

C E Bearden (CE)

Department of Psychiatry, University of California, Los Angeles, Los Angeles, CA, United States; Department Biobehavioral Sciences and Psychology, University of California, Los Angeles, Los Angeles, CA, United States.

J Addington (J)

Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. Electronic address: jmadding@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH